2025
SJR Q1
JCR Q1 · 2,8
OA
189 matched articles
SCIE
Journal detail
World Journal of Surgical Oncology
- Publisher
- BioMed Central Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
14777819
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,761
- Quartile Q1
- H-Index 87
- Cites/doc 2,72
- Docs (3y) 1.134
- Cites (3y) 3.238
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 2,8
- 5Y JIF 2,9
- JCI 0,89
WoS indexes
- SCIE
Subject classification
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 0,761 | 2,8 | 2,9 | 0,89 | Q2 | 87 |
| 2024 | Q1 | Q1 | 0,782 | 2,5 | 2,8 | 0,93 | Q2 | 82 |
| 2023 | Q1 | Q1 | 0,733 | 2,5 | 2,8 | 0,95 | Q2 | 82 |
| 2022 | Q1 | Q1 | 0,774 | 3,2 | 3,2 | 0,99 | Q1 | 82 |
| 2021 | Q1 | Q2 | 0,716 | 3,3 | 3,3 | 0,77 | Q2 | 82 |
| 2020 | Q2 | Q2 | 0,757 | 2,8 | 2,8 | 0,68 | Q2 | 82 |
| 2019 | Q2 | Q2 | 0,703 | 2 | 2 | 0,64 | Q2 | 82 |
| 2018 | — | Q2 | — | 2 | 1,9 | 0,6 | Q3 | — |
| 2017 | Q2 | Q3 | 0,688 | 1,8 | 1,8 | 0,56 | Q3 | 82 |
| 2016 | Q2 | Q3 | 0,684 | 1,6 | 1,7 | — | — | 82 |
| 2015 | Q2 | Q3 | 0,63 | 1,3 | 1,5 | — | — | 82 |
| 2014 | Q2 | Q3 | 0,629 | 1,4 | 1,5 | — | — | 82 |
| 2013 | Q2 | Q3 | 0,585 | 1,2 | 1,2 | — | — | 82 |
| 2012 | Q2 | Q3 | 0,543 | 1,1 | — | — | — | 82 |
| 2011 | Q2 | Q3 | 0,544 | 1,1 | — | — | — | 82 |
| 2010 | Q2 | Q3 | 0,476 | 1,1 | — | — | — | 82 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q3 | Q2 | 179/333 |
| 2025 | SURGERY | SCIE | Q1 | Q2 | 67/321 |
| 2024 | ONCOLOGY | SCIE | Q3 | Q2 | 188/328 |
| 2024 | SURGERY | SCIE | Q1 | Q2 | 70/314 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q2 | 183/322 |
| 2023 | SURGERY | SCIE | Q1 | Q2 | 68/292 |
| 2022 | ONCOLOGY | SCIE | Q3 | Q1 | 145/241 |
| 2022 | SURGERY | SCIE | Q1 | Q1 | 44/213 |
| 2021 | ONCOLOGY | SCIE | Q3 | Q2 | 169/245 |
| 2021 | SURGERY | SCIE | Q2 | Q2 | 68/213 |
| 2020 | ONCOLOGY | SCIE | Q4 | Q3 | 196/242 |
| 2020 | SURGERY | SCIE | Q2 | Q2 | 86/211 |
| 2019 | ONCOLOGY | SCIE | Q4 | Q3 | 207/244 |
| 2019 | SURGERY | SCIE | Q2 | Q2 | 97/210 |
| 2018 | ONCOLOGY | SCIE | Q4 | Q3 | 183/230 |
| 2018 | SURGERY | SCIE | Q2 | Q3 | 91/203 |
| 2017 | ONCOLOGY | SCIE | Q4 | Q3 | 186/223 |
| 2017 | SURGERY | SCIE | Q3 | Q3 | 101/200 |
| 2016 | ONCOLOGY | SCIE | Q4 | — | 180/217 |
| 2016 | SURGERY | SCIE | Q3 | — | 107/197 |
| 2015 | ONCOLOGY | SCIE | Q4 | — | 188/213 |
| 2015 | SURGERY | SCIE | Q3 | — | 118/200 |
| 2014 | ONCOLOGY | SCIE | Q4 | — | 180/211 |
| 2014 | SURGERY | SCIE | Q3 | — | 107/198 |
| 2013 | ONCOLOGY | SCIE | Q4 | — | 171/203 |
| 2013 | SURGERY | SCIE | Q3 | — | 121/204 |
| 2012 | ONCOLOGY | SCIE | Q4 | — | 171/197 |
| 2012 | SURGERY | SCIE | Q3 | — | 122/199 |
| 2011 | ONCOLOGY | SCIE | Q4 | — | 161/196 |
| 2011 | SURGERY | SCIE | Q3 | — | 119/199 |
| 2010 | ONCOLOGY | SCIE | Q4 | — | 156/185 |
| 2010 | SURGERY | SCIE | Q3 | — | 106/188 |